These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8225947)

  • 1. The effect of peripheral inositol injection on rat motor activity models of depression.
    Kofman O; Bersudsky Y; Vinnitsky I; Alpert C; Belmaker RH
    Isr J Med Sci; 1993 Sep; 29(9):580-6. PubMed ID: 8225947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo-inositol attenuates two specific behavioral effects of acute lithium in rats.
    Kofman O; Belmaker RH; Grisaru N; Alpert C; Fuchs I; Katz V; Rigler O
    Psychopharmacol Bull; 1991; 27(3):185-90. PubMed ID: 1775587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygote inositol transporter knockout mice show a lithium-like phenotype.
    Bersudsky Y; Shaldubina A; Agam G; Berry GT; Belmaker RH
    Bipolar Disord; 2008 Jun; 10(4):453-9. PubMed ID: 18452441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium-pilocarpine seizures as a model for lithium action in mania.
    Belmaker RH; Bersudsky Y
    Neurosci Biobehav Rev; 2007; 31(6):843-9. PubMed ID: 17602744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats.
    Williams MB; Jope RS
    Brain Res; 1995 Jul; 685(1-2):169-78. PubMed ID: 7583243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium.
    Agam G; Shapiro Y; Bersudsky Y; Kofman O; Belmaker RH
    Pharmacol Biochem Behav; 1994 Oct; 49(2):341-3. PubMed ID: 7824547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures.
    Kofman O; Sherman WR; Katz V; Belmaker RH
    Psychopharmacology (Berl); 1993; 110(1-2):229-34. PubMed ID: 7870890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol.
    Shaldubina A; Buccafusca R; Johanson RA; Agam G; Belmaker RH; Berry GT; Bersudsky Y
    Genes Brain Behav; 2007 Apr; 6(3):253-9. PubMed ID: 16848785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of various new GABAergics on motor and oral stereotypes with apomorphine in the rat].
    Vamvakidès A; Kassianidès A; Papadopoulou-Daifoti Z
    J Pharmacol; 1985; 16(4):403-11. PubMed ID: 4094437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T.
    McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
    Neuroreport; 2006 Aug; 17(12):1323-6. PubMed ID: 16951578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in dopamine-stimulated gene expression after single-day methamphetamine exposure.
    Belcher AM; O'Dell SJ; Marshall JF
    Synapse; 2009 May; 63(5):403-12. PubMed ID: 19177510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic activity wheel running reduces the severity of kainic acid-induced seizures in the rat: possible role of galanin.
    Reiss JI; Dishman RK; Boyd HE; Robinson JK; Holmes PV
    Brain Res; 2009 Apr; 1266():54-63. PubMed ID: 19248773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents.
    Bristow LJ; Flatman KL; Hutson PH; Kulagowski JJ; Leeson PD; Young L; Tricklebank MD
    J Pharmacol Exp Ther; 1996 May; 277(2):578-85. PubMed ID: 8627534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of N-(4-picolyl)-3,5 dimethylbenzamide (M-14012-4) on stereotyped behavior induced by apomorphine and amphetamine in the rat and mouse].
    Casais PL; Chermat R; Cuenca E; Simón P
    Arch Farmacol Toxicol; 1981 Apr; 7(1):65-72. PubMed ID: 7198897
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-linearity in combined effects of ELF magnetic field and amphetamine on motor activity in rats.
    Pesić V; Janać B; Jelenković A; Vorobyov V; Prolić Z
    Behav Brain Res; 2004 Apr; 150(1-2):223-7. PubMed ID: 15033296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.